The death of Igho Ubiribo should give everyone involved in penile enhancement pause. However one looks at it, be it from the point of view of a urologic surgeon, a patient, or a family member, there’s one cold hard fact: A man underwent elective cosmetic surgery and didn’t survive the process. This was a senseless and ultimately avoidable tragedy.
As a specialist in the field of men’s health and girth enhancement, I need to resist the temptation to speculate as to why a routine procedure ended in the death of a patient. I can say quite frankly that if mortality was a predictable outcome, I would refuse to perform any such procedure.
Why Standardization Matters
After years of research, I came to the conclusion that penile girth enhancement needed to become a defined medical technique rather than remain simply “penile filler.”
Over years of working with HA for penile augmentation, we focused on developing a reproducible method: where the material should be placed, how it should be distributed, how the result should be shaped, how providers should be trained and how problems should be recognized and managed.
That process ultimately became the UroFill® Technique. UroFill providers undergo specific training in the technique rather than simply receiving instructions about which filler to purchase. That distinction is deliberate.
It would be irresponsible for me to suggest that any technique can eliminate every possible complication. Every medical procedure carries risk. What physicians can do is identify those risks, study them, develop protocols to reduce them, and train other physicians to perform the procedure consistently.
Recent medical literature supports the importance of that approach. A 2025 review of penile-enhancement complications noted that HA generally has a more favorable complication profile than several permanent injectable materials when used with standardized, low-volume protocols. The same review emphasizes that complications still occur and require clinicians who know how to recognize and manage them.
The Girth Enhancement Field Is Growing Faster Than Its Standards
Penile enhancement is no longer an obscure corner of aesthetic medicine. Men see these procedures on Instagram, TikTok, clinic websites and advertisements while traveling abroad. They are offered branded procedures, package prices and dramatic promises of additional circumference.
What patients generally cannot evaluate is the part that matters most:
- What training does the person holding the syringe actually have?
- Is that physician a qualified andrologist?
- Is there a standardized protocol?
- What volumes are normally administered?
- What complications has the provider encountered?
- What happens if a vascular event, infection, severe swelling or other unexpected complication develops?
- Does the providing clinic have the medical capability to recognize an emergency?
And perhaps the most important question:
Is the provider performing a defined technique, or simply injecting filler into a penis?
The difference is subtle, yet profound. Aesthetic procedures have become, for better or worse, regarded as near-effortless and risk-free. Patients see a few injections, a short appointment and no operating room, and naturally conclude that what is happening is relatively minor.
The main idea to keep in mind is that “minimally invasive” does not mean medically trivial.
When we put a needle into human tissue and introduce a substance into the body, anatomy still applies. Physiology still applies, as do complications. The administering surgeon’s responsibility still applies.
The Need for Transparency and Training
I do not believe the lesson from Igho Ubiribo’s death should be that men must be frightened away from penile enhancement. What I do believe is that physicians offering these treatments have an obligation to make this field better.
We need greater transparency about complications, meaningful physician training rather than weekend familiarity with a product, reproducible protocols, continued research into appropriate materials, quantities, injection planes and patient selection, and constant documentation about potential complications.
The existing literature suggests that HA penile augmentation can produce meaningful girth increases with relatively low complication rates in appropriately performed procedures, but the literature remains limited, follow-up is often short, and serious complications are possible.
Patients deserve to hear both halves of that sentence.
I have devoted much of my career to male sexual medicine and to improving the way penile procedures are performed. If this field continues to grow, and I believe it will, then the responsibility of those of us working in it is not merely to make these procedures more available; it is to make them more rigorous.
Whatever the investigation ultimately determines about the exact circumstances of Igho Ubiribo’s death, the appropriate response from andrologists should not be defensiveness, sensationalism or opportunism, but rather scrutiny:
- What happened?
- What can we learn?
- What practices can be improved?
- What can we do to reduce the possibility that another patient experiences the same outcome?
Patient health and safety is non-negotiable.
